2 results match your criteria: "University Hospital Marqués de Valdecilla University of Cantabria-IFIMAV[Affiliation]"
"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".
BMC Med Genet
December 2011
Endocrinology Service, University Hospital Marqués de Valdecilla University of Cantabria-IFIMAV, Avda, de Valdecilla, Santander 39008, SPAIN.
Background: Primary hyperparathyroidism (PHPT) affects mainly cortical bone. It is thought that parathyroid hormone (PTH) indirectly regulates the activity of osteoclasts by means of the osteoprotegerin/ligand of the receptor activator of nuclear factor-κβ (OPG/RANKL) system. Several studies have confirmed that OPG (osteoprotegerin) and RANKL (ligand of the receptor activator of nuclear factor-κβ) loci are determinants of bone mineral density (BMD) in the general population.
View Article and Find Full Text PDFGenome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.
Neurobiol Aging
July 2012
Neurology Department, University Hospital Marqués de Valdecilla, Fundación Marqués de Valdecilla (University of Cantabria) IFIMAV and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Santander, Spain.
The aim of our study was to discover genomic variations related to variant Creutzfeldt-Jakob disease (vCJD) susceptibility. A genome-wide association analysis with most vCJD samples available in the world was performed. A series of 93 vCJD UK patients and 1504 UK controls were included in the discovery stage.
View Article and Find Full Text PDF